SCINAI IMMUNOTHERAPEUTICS LTD. Shareholders' Equity
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) had Shareholders' Equity of $8.10 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-04-01
- 2025-12-31: Stockholders' Equity Attributable to Parent $8.10M.
- 2025-06-30: Stockholders' Equity Attributable to Parent $7.86M.
- 2024-12-31: Stockholders' Equity Attributable to Parent $9.98M.
- 2024-06-30: Stockholders' Equity Attributable to Parent -$7.28M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2025-12-31 | $8.10M 20-F · filed 2026-04-01 |
| 2025-06-30 | $7.86M 6-K · filed 2025-09-02 |
| 2024-12-31 | $9.98M 20-F · filed 2026-04-01 |
| 2024-06-30 | -$7.28M 6-K · filed 2025-09-02 |
| 2023-12-31 | -$4.57M 20-F · filed 2026-04-01 |
| 2023-06-30 | -$7.11M 6-K · filed 2024-09-09 |
| 2023-03-31 | -$4.81M 6-K/A · filed 2023-08-18 |
| 2022-12-31 | -$1.76M 20-F · filed 2026-04-01 |
| 2022-06-30 | $3.26M 6-K/A · filed 2023-08-18 |
| 2022-03-31 | -$862.00K 6-K/A · filed 2023-08-18 |
| 2021-12-31 | $982.00K 20-F · filed 2025-05-07 |
| 2020-12-31 | -$15.04M 20-F · filed 2024-05-15 |